Anagenics Appoints internal CEO
- Health and beauty technologies business, Anagenics (AN1), has appointed its financial controller Matthew Dudek as acting CEO
- Following the resignation of CEO and Managing Director Maria Halasz, Mr Dudek’s new position was effective from February 28
- Under a 12 month contract, Mr Dudek is on a base salary of $250,000 and during this time he and the company will determine whether a permanent CEO role is suitable
- The new CEO says he is honoured to take over the position and looks forward to delivering on AN1’s key objectives and leading the next stage of growth
- Shares have been trading grey at 4.9 cents at 2:20 pm AEDT
